Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 15/20 | 0.83 |
| ▸ | MEN1 | O00255 | 13/20 | 0.83 |
| ▸ | CTDSP1 | Q9GZU7 | 7/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.79 |
| ▸ | POLB | P06746 | 7/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | PTPN12 | Q05209 | 4/20 | 0.63 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.63 |
| ▸ | PTPN22 | Q9Y2R2 | 4/20 | 0.63 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.63 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12008604 | 0.91 | KMT2A (1.00) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL17319549 | 0.91 | KMT2A (1.00) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL18539157 | 0.85 | KMT2A (0.84) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL31377010 | 0.84 | KMT2A (0.75) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL12008572 | 0.83 | KMT2A (0.89) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL12008778 | 0.81 | KMT2A (0.90) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL12008592 | 0.80 | KMT2A (1.00) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL12008570 | 0.79 | KMT2A (1.00) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL17319563 | 0.79 | KMT2A (0.83) | KMT2AMEN1CTDSP1BLMTDP1 | |
| SCHEMBL17319553 | 0.79 | KMT2A (1.00) | KMT2AMEN1CTDSP1BLMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9173871-B2 | Oxazole and thiazole compounds as beta-catenin modulators and uses thereof | NEW YORK UNIVERSITY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9173871-B2 | Oxazole and thiazole compounds as beta-catenin modulators and uses thereof | NEW YORK UNIVERSITY (US) | 2015-11-03 | — | — | US | disclosed |
| US-20120264744-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | UNITED STATES GOVERNMENT | 2012-10-18 | — | — | US | disclosed |
| US-20120264744-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | UNITED STATES GOVERNMENT | 2012-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264744-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | CTNNB1, CTNNA1, CTNNBL1 | KMT2A 4503/4885MEN1 3747/4885CTDSP1 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.